There is an increasing trend towards gathering early toxicology data to provide clues to a drug candidate’s potential toxicity prior to initiating IND-enabling preclinical toxicology programs. Conducting exploratory toxicology studies can minimize the risk of failure during preclinical studies, provide information on a drug candidate’s toxicology risks, and assist with the design of early GLP toxicology studies.
At IITRI, our highly experienced PhD, DABT study directors can assist with the design of an exploratory toxicology study customized to the requirements of your program.
Exploratory toxicology studies include:
- Single and repeat dose range finding toxicology
- Acute, subchronic and chronic toxicology
Contact Us to find out how exploratory toxicology studies can de-risk your drug development program.